mRNA Cancer Vaccines and Therapies: An Overview
Advarra
JANUARY 11, 2024
Adoptive T Cell therapies, therapeutic antibodies, and immunomodulatory proteins represent just some of the potentially beneficial treatment strategies for successful mRNA cancer trials. They must also seek institutional review board (IRB) approval, and often, oversight by an institutional biosafety committee (IBC) is also required.
Let's personalize your content